rs149827237
Variant summary
Our verdict is Pathogenic. Variant got 13 ACMG points: 13P and 0B. PM1PM2PP3PP5_Very_Strong
The NM_001130987.2(DYSF):c.853C>T(p.Arg285Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000159 in 1,614,088 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R285Q) has been classified as Uncertain significance.
Frequency
Consequence
NM_001130987.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
DYSF | NM_001130987.2 | c.853C>T | p.Arg285Trp | missense_variant | 8/56 | ENST00000410020.8 | |
DYSF | NM_003494.4 | c.757C>T | p.Arg253Trp | missense_variant | 7/55 | ENST00000258104.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
DYSF | ENST00000410020.8 | c.853C>T | p.Arg285Trp | missense_variant | 8/56 | 1 | NM_001130987.2 | A1 | |
DYSF | ENST00000258104.8 | c.757C>T | p.Arg253Trp | missense_variant | 7/55 | 1 | NM_003494.4 | A1 |
Frequencies
GnomAD3 genomes ? AF: 0.0000460 AC: 7AN: 152102Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000123 AC: 31AN: 251448Hom.: 0 AF XY: 0.000140 AC XY: 19AN XY: 135896
GnomAD4 exome AF: 0.000170 AC: 249AN: 1461868Hom.: 0 Cov.: 31 AF XY: 0.000166 AC XY: 121AN XY: 727230
GnomAD4 genome ? AF: 0.0000460 AC: 7AN: 152220Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74422
ClinVar
Submissions by phenotype
not provided Pathogenic:5
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Apr 18, 2023 | Observed in the homozygous state in one individual with isolated elevated creatine kinase levels who had only a mild reduction of dysferlin on western blot analysis (Nguyen et al., 2005); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 27666772, 23891399, 18853459, 25868377, 16010686, 28888072, 27017278, 33215690, 31589614, 33715265, 33610434, 36672942, 30919934) - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | May 25, 2017 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jan 03, 2024 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jun 01, 2018 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Feb 18, 2020 | PS4_moderate, PM2, PM3 - |
Autosomal recessive limb-girdle muscular dystrophy type 2B Pathogenic:3
Likely pathogenic, criteria provided, single submitter | clinical testing | Johns Hopkins Genomics, Johns Hopkins University | Jun 16, 2020 | This DYSF variant (rs149827237) is rare (<0.1%) in a large population dataset (gnomAD: 32/282838 total alleles; 0.011%; no homozygotes) and has an entry in ClinVar. This variant has been reported previously in combination with another DYSF variant in individuals affected with LGMDR2 and in a homozygous state in an individual with isolated hyperCKemia. Three bioinformatic tools queried predict that p.Arg285Trp would be damaging, and the arginine residue at this position is strongly conserved across the species assessed. This variant is not predicted to affect normal exon 8 splicing, although this has not been confirmed experimentally to our knowledge. We consider this variant to be likely pathogenic. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | MGZ Medical Genetics Center | Nov 18, 2021 | - - |
Likely pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Mar 01, 2021 | - - |
Distal myopathy with anterior tibial onset;C1850889:Autosomal recessive limb-girdle muscular dystrophy type 2B;C4551973:Miyoshi muscular dystrophy 1 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Sep 24, 2021 | - - |
Miyoshi muscular dystrophy 1 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Oct 23, 2023 | - - |
Qualitative or quantitative defects of dysferlin Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Invitae | Jan 31, 2024 | This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 253 of the DYSF protein (p.Arg253Trp). This variant is present in population databases (rs149827237, gnomAD 0.04%). This missense change has been observed in individual(s) with clinical features of dysferlinopathies (PMID: 16010686, 18853459, 25868377, 27666772, 30919934; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 284800). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt DYSF protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at